Infectious Diseases

Host: Carol Wysham

Guest: Deepak Vashishth, PhD

Guest: Bowen Wang

Can we predict when a patient with COVID-19 requires hospitalization? To answer this question, Dr. Carol Wysham is joined by Dr. Deepak Vashishth and Mr. Bowen Wang from the Rensselaer Polytechnic Institute to share data from their study on the impact of glycemic levels and common medications on COVID-19 severity in patients with type 2 diabetes.

Host: John Russell, MD

Guest: Benjamin Abramoff, MD, MS

Once a patient is discharged from the hospital after battling COVID-19, the war they face with this disease may not be over. In fact, many patients continue to experience long-term effects, which is why some institutions have formed clinics that are solely dedicated to caring for these patients. To learn more about how one such clinic is helping patients manage these devastating effects, Dr. John Russell speaks to physiatrist Dr. Benjamin Abramoff from the Post-COVID Assessment and Recovery Clinic at Penn Medicine in Philadelphia.

Host: Charles Turck, PharmD, BCPS, BCCCP

Guest: William Schaffner, MD

From widespread variants to the threat of a twindemic -- what has the COVID-19 pandemic taught us? And can we learn to coexist with this virus? Dr. Charles Turck is joined by Dr. William Schaffner from the National Foundation for Infectious Diseases to discuss what's on the horizon for the pandemic.

Host: Hector O. Chapa, MD, FACOG

Guest: Linda Bradley, MD

While many people across the country have access to COVID-19 vaccines, there are certain communities where access is not as easy. So what can we do to address the vaccination gaps and barriers to care during the COVID-19 pandemic and beyond? Find out with Dr. Hector Chapa as he speaks with Dr. Linda Bradley from Case Western Reserve University, who shares a brief history of the presence of social determinants of health and racial disparities across our nation and how they impact our current vaccination efforts.

Host: Charles Turck, PharmD, BCPS, BCCCP

Guest: Chris Beyrer, MD, MPH

Amid the ongoing COVID-19 pandemic, countries in Sub-Saharan Africa are also facing high rates of HIV and AIDS prevalence. But after the success of the mRNA COVID-19 vaccines, could an mRNA vaccine for HIV/AIDS be on the horizon? Here to explore emerging research and the potential role that mRNA technology might have in battling this global epidemic is Dr. Chris Beyrer, a Professor of Epidemiology at the Johns Hopkins Bloomberg School of Public Health in Baltimore, Maryland.

Guest: Jeniffer Hernandez, PhD

Over 1.5 million viruses could potentially cause a future pandemic. Could antibodies be the key to neutralizing those viruses? Here to share how future vaccination efforts might incorporate neutralizing antibodies and her research on preventing future pandemics is Dr. Jeniffer Hernandez, Associate Professor of Biopharmaceutical Sciences at the Keck Graduate Institute.

Host: John Russell, MD

Guest: Jessica Malaty Rivera, MS

Social media and the ability to quickly spread information across the internet has allowed misinformation surrounding COVID-19 vaccines and the disease itself to spread like wildfire. But the good news is that when armed with effective counseling strategies and data from initiatives like the COVID-19 Tracking Project, we as clinicians can help stop the spread of harmful conspiracies and myths. Joining Dr. John Russell to talk about those essential strategies and the COVID-19 Tracking Project is infectious disease epidemiologist Ms. Jessica Rivera.

Host: Charles Turck, PharmD, BCPS, BCCCP

Guest: Emily Carroll, JD, MSW

The No Surprises Act aims to protect consumers from surprise medical bills. But how exactly does it go about doing that, and what’s the current status of its implementation? Joining Dr. Charles Turck to share progress and challenges associated with the No Surprises Act is Ms. Emily Carroll, a senior legislative attorney for the American Medical Association's Advocacy Resource Center.

No Label: Patricia K. Coyle, MD, FAAN, FANA

No Label: Douglas R. Jeffrey, MD, PhD

Is EBV the Cause of Multiple Sclerosis? Viruses have long been implicated in the pathogenesis of multiple sclerosis, but no single virus has been found to be the cause. Could Epstein-Barr Virus—or EBV—be the culprit? Listen to the experts debate!

Host: Jerome Lisk, MD, MBA, M.S., FAAN

Guest: Tissa Wijeratne MD PhD FRACP FRCP FAAN

Since the onset of the COVID-19 pandemic, researchers and clinicians alike have strived to address the mysteries surrounding the virus, including its long-term side effects on patients. So what we do need to know about the emerging syndrome pointing to COVID-19’s neurological and cognitive impacts? To find out, Dr. Jerome Lisk is joined by Dr. Tissa Wijeratne, the Director of the Department of Neurology and Stroke Services at the University of Melbourne, to talk about post-COVID-19 neurological syndrome.